Latest News

FDA accepts NDA for epinephrine sublingual film to treat type 1 allergic reactions | Image credit: Contemporary Pediatrics
FDA accepts NDA for epinephrine sublingual film to treat type 1 allergic reactions

June 17th 2025

The federal agency has assigned a target action date of January 31, 2026, for a decision.

FDA approves garadacimab-gxii to prevent HAE attacks in patients aged 12 years, older | Image credit: Contemporary Pediatrics
FDA approves garadacimab-gxii to prevent HAE attacks in patients aged 12 years, older

June 17th 2025

FDA will not meet original PDUFA data for sebetralstat to treat HAE | Image Credit: Contemporary Pediatrics
FDA will not meet original PDUFA date for sebetralstat to treat HAE

June 16th 2025

FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis | Image Credit: Contemporary Pediatrics
FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis

June 16th 2025

Father’s teen diet linked to children’s healthy eating habits | Image Credit: © nadianb - stock.adobe.com.
Father’s teen diet linked to children’s healthy eating habits

June 16th 2025

Latest Videos
Podcasts

All News

© 2025 MJH Life Sciences

All rights reserved.